Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=98747b81-e021-4eaa-83fe-d286569c8765&Preview=1 Date 2/28/2013 Company Name RaftOut Mailing Address 95 Chestnut Third Floor Providence, RI 02903 Company Description People love going to events with their friends, but getting them to commit in advance is hard. RaftOut makes it easy for groups of friends to get organized by pulling the group’s conversation from email, … Continue reading “RaftOut Secures $20,000 Seed Funding”
Category: Boston
Infikno Secures $20,000 Seed Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6254cb1a-d87b-4dd6-b1be-d48d0061ffd6&Preview=1 Date 2/28/2013 Company Name Infikno Mailing Address 95 Chestnut Third Floor Providence, RI 02903 Company Description Infikno is a content delivery platform for fans and enthusiasts that delivers the content you crave about the things you love. Website http://www.infikno.com Transaction Type Accelerator Transaction Amount $20,000 Transaction Round Seed Proceeds Purposes The … Continue reading “Infikno Secures $20,000 Seed Funding”
ZoomTilt Garners $20,000 Seed Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5dda4816-743d-43fd-a443-deae69c251a5&Preview=1 Date 2/28/2013 Company Name ZoomTilt Mailing Address 95 Chestnut Third Floor Providence, RI 02903 Company Description ZoomTilt is a media technology company that delivers social video marketing solutions to brands. Our integrated model matches brands and agencies with top-caliber creative talent, content measurement analytics and unique video distribution approaches to generate … Continue reading “ZoomTilt Garners $20,000 Seed Funding Round”
Eventcheq Obtains $20,000 Seed Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4edff244-876a-4e4d-adce-fb132a2912bb&Preview=1 Date 2/28/2013 Company Name Eventcheq Mailing Address 95 Chestnut Third Floor Providence, RI 02903 Company Description Collect virtual stubs and badges for events you attend. Share and brag about them with your friends on Facebook and Twitter. Receive personalized recommendations for upcoming events near you and be notified when tickets go … Continue reading “Eventcheq Obtains $20,000 Seed Round”
Splashscore Obtains $20,000 Seed Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=589eff86-6c51-4cba-8c39-feb478284001&Preview=1 Date 2/28/2013 Company Name Splashscore Mailing Address 47 Farquhar Road Newtonville, MA 02460 Company Description Each time you receive likes and comments on your Facebook posts, we will give you points. Likes are worth 1 point and comments are worth 2 points. We then give bonus points based on 40 other … Continue reading “Splashscore Obtains $20,000 Seed Financing”
Third Rock’s Bet on Lotus Tissue Repair Generates Big Return
Third Rock Ventures has seen its biotech startup companies achieve some impressive things since it got going in 2007. But now the firm can point to the first venture-style return on one of its home-grown startups. Dublin, Ireland-based Shire (NASDAQ: [[ticker:SHPG]]) shed some light on Third Rock’s biggest return in a regulatory filing this week. … Continue reading “Third Rock’s Bet on Lotus Tissue Repair Generates Big Return”
Boston Roundup: HubSpot, Harvard, Avid, Polar, Proletariat
Some tidbits that we need to note from the past week or so around the Boston region: —HubSpot, the fast-growing online marketing software company, posted its annual report online to tout another year of growth. The company says its sales grew 82 percent to $52.5 million in 2012. HubSpot also continues to make noise about going … Continue reading “Boston Roundup: HubSpot, Harvard, Avid, Polar, Proletariat”
Retroficiency Secures $2,732,402 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1af3c0f4-254d-4009-aa40-648d56ff3669&Preview=1 Date 2/27/2013 Company Name Retroficiency Mailing Address 180 Canal Street Boston, MA 02114 Company Description Retroficiency reduces time and expense for ESCOs, facilities managers and other professionals in evaluating energy efficiency measures throughout the audit process. Website http://www.retroficiency.com Transaction Type Venture Equity Transaction Amount $2,732,402 Transaction Round Undisclosed Proceeds Purposes Proceeds … Continue reading “Retroficiency Secures $2,732,402 New Round”
Design by Educators Secures $99,500 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1c0c8e42-84df-4419-bafb-69be0ac735d9&Preview=1 Date 2/27/2013 Company Name Design by Educators Mailing Address Undisclosed Cambridge, MA 02138 Company Description We worked hard to build an amazing prototype. But now we need real teachers to beta test Quick Key. My goal was to recruit 100 teachers with the video. As of tonight, over 1,000 people have … Continue reading “Design by Educators Secures $99,500 New Funding Round”
HighRoads Lands $262,500 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=cd168ed0-d001-4de8-9086-a444c0fd2a16&Preview=1 Date 2/27/2013 Company Name HighRoads Mailing Address 120 Presidential Way Woburn, MA 01801 Company Description IE-Engine Inc. is the leading developer of Human Resource Cost Management (HRCM) software. The Company’s Web-based applications enable HR decision makers at Global 1000 organizations to make better strategic decisions, reduce costs and increase the quality … Continue reading “HighRoads Lands $262,500 New Financing”
Concert Pharma, Jazz Pharma Strike $120M Deal for Narcolepsy
If there was ever an occasion to play some Miles Davis around a Boston biotech company’s office, today is the day. Lexington, MA-based Concert Pharmaceuticals has the right to play it cool, or at least crack a few music jokes, after striking a collaboration with another musically inspired company—Dublin, Ireland-based Jazz Pharmaceuticals (NASDAQ: [[ticker:JAZZ]]). The … Continue reading “Concert Pharma, Jazz Pharma Strike $120M Deal for Narcolepsy”
Failure and Redemption
What’s gone and what’s past help Should be past grief. —William Shakespeare – The Winter’s Tale We give abundant advice to founders about how to make startups succeed, yet we offer few models about dealing with failure. So here’s mine. ——– In my experience, living through failure has 6 stages: Stage 1: Shock and Surprise … Continue reading “Failure and Redemption”
Spark Capital Closes Fourth Fund at $450M
Boston’s Spark Capital, a venture firm with high-profile investments in Twitter, Tumblr, and Foursquare, has closed its fourth fund at $450 million. Founded in 2005 by Todd Dagres, Santo Politi, and Paul Conway, Spark started with an emphasis on early stage, consumer-focused technology and media companies. It’s since expanded its focus a bit, with investments … Continue reading “Spark Capital Closes Fourth Fund at $450M”
New Partner at Quiet Hambrecht Fund Takes ‘Moneyball’ Approach to VC
Thomas Thurston says we’ve entered “the era of the Moneyball VC,” and no less a name than investment banking pioneer Bill Hambrecht is placing a bet on this Northwest-based data scientist’s formula for picking winners. Over the last seven years, Thurston (pictured) has been developing algorithms—first at Intel Capital, and later in collaboration with Harvard … Continue reading “New Partner at Quiet Hambrecht Fund Takes ‘Moneyball’ Approach to VC”
TechStars Boston Spring 2013 Class Announced
TechStars, the top-shelf startup accelerator program, is kicking off its newest Boston class with a group that covers a wide array of sectors and includes several teams from outside the U.S. It’s the sixth time TechStars has run its three-month “bootcamp” for entrepreneurship in Boston, which is one of the program’s core cities. TechStars began in … Continue reading “TechStars Boston Spring 2013 Class Announced”
Cubist Grabs Option to Acquire Adynxx, Getting Drug for Pain
Cubist Pharmaceuticals has been looking to diversify for a while, to get something more than antibiotics it can sell to hospitals. Now it’s getting the rights to what it hopes will be a big new pain drug. The Lexington, MA-based biotech company (NASDAQ: [[ticker:CBST]]) said today it has obtained an exclusive right to acquire San … Continue reading “Cubist Grabs Option to Acquire Adynxx, Getting Drug for Pain”
With Fluorine Tech, SciFluor Aims to Vindicate “Me-Too” Drugs
Me-too drugs, knockoffs, copycats, retreads—they’re all names for new pharmaceuticals patterned after drugs already proven to work. The number of such labels alone signals the type of passionate commentary surrounding these products. Critics have charged pharmaceutical companies with churning out these modified drugs to fight common ailments like high cholesterol or heartburn without proving that … Continue reading “With Fluorine Tech, SciFluor Aims to Vindicate “Me-Too” Drugs”
Active Endpoints Bought by Informatica in Cloud Workflow Deal
Chalk up another acquisition of a Boston tech company by a Silicon Valley giant. Waltham, MA-based Active Endpoints has been acquired by data-integration software maker Informatica (NASDAQ: [[ticker:INFA]]), of Redwood City, CA. The news was buried in a press release announcing Informatica’s latest cloud-based product. It’s not immediately clear when the acquisition happened, or what … Continue reading “Active Endpoints Bought by Informatica in Cloud Workflow Deal”
As MWC Opens in Barcelona, We’re All on the Eve of Disruption
It’s sunny but cold in Barcelona today, as more than 72,000 telecom and technology professionals arrive for the first day of the Mobile World Congress. They come for the spinning, networking, and opportunity seeking—and perhaps for the tapas and Spanish wine. Yet the show is so big and so dispersed that most companies begin trumpeting … Continue reading “As MWC Opens in Barcelona, We’re All on the Eve of Disruption”
Zuckerberg Takes a Small Step in Right Direction, Backing Biotech
Woody Allen is often quoted as saying 80 percent of life is just showing up. This past week Facebook CEO Mark Zuckerberg wrote a decent check, and just as important, he showed up for life sciences. It’s a small gesture, but a start. The social-networking wizard took some time out of his week to stop … Continue reading “Zuckerberg Takes a Small Step in Right Direction, Backing Biotech”
Informatica Acquires Active Endpoints for Undisclosed Sum
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=38714a34-a24d-4e16-93f7-987ba473c9fe&Preview=1 Date 2/25/2013 Company Name Active Endpoints Mailing Address 230 Third Avenue 3rd Floor Waltham, MA 02451 Company Description Active Endpoints is the leading developer of Visual Orchestration Systems. VOS empowers line of business project teams to create applications using services and industry standards, making their businesses more agile and effective. Active … Continue reading “Informatica Acquires Active Endpoints for Undisclosed Sum”
Dan Bricklin, Apperian, ByteLight Join Mobile Madness Lineup on March 19
Too many good people, too few slots. Such is the curse of Mobile Madness. Nevertheless we forge on. I’m pleased to announce a few more speakers for Mobile Madness 2013, our fifth annual mobile conference on March 19 at Microsoft NERD in Cambridge, MA. I hope to have the agenda finalized by next week. —Dan … Continue reading “Dan Bricklin, Apperian, ByteLight Join Mobile Madness Lineup on March 19”
Abierto Networks Secures $100,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b7c18cc8-3c33-49a4-9ae8-0e6c67ea2d46&Preview=1 Date 2/23/2013 Company Name Abierto Networks Mailing Address 11 Sanborn Lane Eliot, ME 03903 Company Description Abierto Networks is a value-added solutions provider and integrator of Digital Technologies, specializing in High Speed Payments and Digital Retail Marketing & Promotional Technology Solutions exclusively for the North American Convenience Store and Retail Petroleum … Continue reading “Abierto Networks Secures $100,000 New Funding Round”
3Doodler Secures $1,697,584 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=088e076a-8ee9-4a04-a5f3-97a21964b18a&Preview=1 Date 2/23/2013 Company Name 3Doodler Mailing Address Undisclosed Boston, MA 02101 Company Description 3Doodler is the brainchild of Peter Dilworth and Max Bogue, co-founders of WobbleWorks LLC. The 3Doodler, the world’s first 3D printing pen. Website http://www.the3doodler.com Transaction Type Venture Equity Transaction Amount $1,697,584 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes … Continue reading “3Doodler Secures $1,697,584 New Round”
East Coast Life Sciences Roundup: IBM, ImmunoGen, Breakthrough Prize, & More
The symbiotic ties between industry and university scientists were a big theme this week in East Coast news. Some top academic researchers became instant millionaires as tech moguls honored their biomedical innovations, and new university institutes launched projects to accelerate progress in the pharmaceutical world. And the FDA’s approval of a new Genentech cancer drug … Continue reading “East Coast Life Sciences Roundup: IBM, ImmunoGen, Breakthrough Prize, & More”
Genentech, ImmunoGen Win FDA OK for Souped-Up Breast Cancer Drug
Genentech’s scientists have long wondered about what would happen if they could deliver a more powerful version of their original hit antibody drug for breast cancer. Now they’ll see. The South San Francisco-based company, a unit of Roche, said today that it won FDA clearance to start selling ado-trastuzumab emtansine (Kadcyla) as a new treatment … Continue reading “Genentech, ImmunoGen Win FDA OK for Souped-Up Breast Cancer Drug”
Battery Ventures’ Recent Fund Performance: Nothing Special
With this week’s news that Battery Ventures has closed new venture capital funds worth a combined $900 million, we thought it might be interesting to take a look back at the firm’s recent performance. So we turned to information from state pension funds, one of the few sources of publicly available information about venture capital … Continue reading “Battery Ventures’ Recent Fund Performance: Nothing Special”
Adimab Grows Up, Looks to Pay Off the VCs In Unusual Way
Adimab has raised a shade under $40 million in venture capital since it was founded in 2007. If things break the way co-founder and CEO Tillman Gerngross expects, this could be the year the VCs get their money bank without him going through the trouble of an IPO, or selling out to some Big Pharma … Continue reading “Adimab Grows Up, Looks to Pay Off the VCs In Unusual Way”
I Switched from Mint.com to Pageonce. Maybe You Should Too.
[Update: As of May 2013, Pageonce has officially changed the name of its app and service to Check.] For more than a decade, I was a faithful user of Quicken, Intuit’s desktop personal finance program. I stopped using it in 2008 after Mint.com came along, giving me the ability to monitor all my accounts from … Continue reading “I Switched from Mint.com to Pageonce. Maybe You Should Too.”
Living Proof Receives $30,000,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2a696363-b656-476a-8c70-68c0af62f4e6&Preview=1 Date 2/22/2013 Company Name Living Proof Mailing Address 301 Binney Street 1st Floor Cambridge, MA 02142 Company Description Living Proof, Inc. provides materials and products for hair care in the United States. It offers straight making no frizz styling sprays, creams, and treatments; and wave shaping curl defining no frizz styling … Continue reading “Living Proof Receives $30,000,000 New Financing Round”
BioScale Garners $3,827,004 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a6f4ce14-4220-4d33-9cf7-71f3b5a1e0db&Preview=1 Date 2/22/2013 Company Name BioScale Mailing Address 4 Maguire Road Lexington, MA 02421 Company Description At BioScale, we develop, manufacture and promote a sophisticated protein measurement technology to accelerate drug discovery, development and production of biological and pharmaceutical products. Website http://www.bioscale.com Transaction Type Debt Transaction Amount $3,827,004 Transaction Round Undisclosed Proceeds … Continue reading “BioScale Garners $3,827,004 New Financing”
Pulmatrix Receives $3,500,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8f1a9a5f-ce10-4715-b3a3-bc47443ebc2e&Preview=1 Date 2/22/2013 Company Name Pulmatrix Mailing Address 99 Hayden Avenue Lexington, MA 02421 Company Description Pulmatrix Inc. is a pharmaceutical company developing inhalable aerosols and enabling technologies that help control respiratory infectious disease and human-source airborne contamination. Website http://www.pulmatrix.com Transaction Type Debt Transaction Amount $3,500,000 Transaction Round Undisclosed Proceeds Purposes Proceeds … Continue reading “Pulmatrix Receives $3,500,000 New Funding Round”
SynapDx Obtains $2,000,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5a301993-b1af-4cc1-aed7-0adcee433a2b&Preview=1 Date 2/22/2013 Company Name SynapDx Mailing Address 153 Cordaville Road Southborough, MA 01772 Company Description SynapDx was formed to develop and commercialize blood-based diagnostic tests for the early detection of autism. Website http://www.synapdx.com Transaction Type Venture Equity Transaction Amount $2,000,000 Transaction Round Undisclosed Proceeds Purposes This investment will support the clinical … Continue reading “SynapDx Obtains $2,000,000 New Financing Round”
Battery Ventures Closes New Funds at $900M
Battery Ventures, a major Boston-area VC firm, has raised two new funds that total $900 million. The firm says its approach will remain pretty consistent—covering a broad array of bets on companies in several technology sectors, at several different stages of growth. Battery Ventures, which also has offices in Silicon Valley and Israel, is putting … Continue reading “Battery Ventures Closes New Funds at $900M”
Track180 Builds iPad App to Bring More Context, Balance to Online News
The best entrepreneurs are an elusive mix of tech-business expert, clear-headed thinker, contrarian, psychologist, and elevator repairman. Because, really, if you know how to fix elevators, you can pretty much do anything. That would apply to Drue Hontz, the founder and CEO of Track180, a startup in New Haven, CT, that’s trying to reinvent how … Continue reading “Track180 Builds iPad App to Bring More Context, Balance to Online News”
Shedding Baggage, Alnylam Turns a Corner
What convinces investors that a drug discovery company is likely to bring products to the market, and rewards to shareholders? It comes down to just a few things: Proprietary biology. Confident management. Experience driving products into clinical trials and onto the market. Enough of a story to be able to raise money. And the likelihood, … Continue reading “Shedding Baggage, Alnylam Turns a Corner”
With $30M in Financing, Living Proof Primps for More Good Hair Days
Cambridge, MA-based Living Proof says today it has raised $30 million to expand its line of hair care products, and to support the development and commercialization of additional beauty products. In today’s statement, the company says it also has begun its first national marketing campaign with actress Jennifer Aniston and her world famous hair. Living … Continue reading “With $30M in Financing, Living Proof Primps for More Good Hair Days”
Innovations in Financial Technology: Wisdom of the Crowd
It is of particular interest to me when an established industry begins to innovate and move in new directions. Financial technology has been an active area of innovation all along, but the advent of social media and crowd sourcing has infused new life to the sector. Aside from crowdfunding, here at 1M/1M we are also … Continue reading “Innovations in Financial Technology: Wisdom of the Crowd”
E4 Health Secures $3,500,000 Series B Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4123345e-39a4-4a16-be04-81f12a2968f2&Preview=1 Date 2/21/2013 Company Name E4 Health Mailing Address 55 Cedar Street Providence, RI 02903 Company Description E4 Health was founded in 2011 by Bill Mulcahy, CEO, and Cindy Sheriff, President and COO. Both founders have extensive backgrounds in health care consulting, the employee assistance sector, work-family benefits, and the insurance industry. … Continue reading “E4 Health Secures $3,500,000 Series B Financing Round”
Aaron Swartz Prosecutor: Legal System Needs Mental Health Fixes
The top federal prosecutor in the case of Internet activist Aaron Swartz says the young man’s suicide was “a tremendous tragedy” that points to the need for better mental health services in the broader court system. In an interview with Boston NPR station WBUR, Boston-based U.S. Attorney Carmen Ortiz declined to delve into the details … Continue reading “Aaron Swartz Prosecutor: Legal System Needs Mental Health Fixes”
Boston Deals: CounterTack, E4 Health, MassChallenge
A few short news items to catch up on from around the New England innovation scene—and beyond: —CounterTack, a digital security firm that relocated to Waltham in 2011, has raised some $4.3 million in equity, according to an SEC filing. CounterTack, which was previously known as NeuralIQ, raised a $9.5 million Series A round in … Continue reading “Boston Deals: CounterTack, E4 Health, MassChallenge”
Facebook, Google Moguls Give $33M in Prizes to Biomedical Stars
[Updated 11:35 am with Zuckerberg comment] Some of the highest achievers in technology are giving away a lot of money to people who have made some of the biggest achievements in biotech. Facebook’s Mark Zuckerberg and his wife Priscilla Chan, along with Google’s Sergey Brin and his wife Anne Wojcicki, announced today they have come … Continue reading “Facebook, Google Moguls Give $33M in Prizes to Biomedical Stars”
Ed-Tech Isn’t for Wimps: Noodle’s Katzman on Building a Winner
Technology entrepreneurs are increasingly turning their sights on education, with visions of liberating knowledge from the textbook publishing cabals and driving down the costs that lead to heavy student loan debt. That’s a good thing. But just like any other sector drawing a lot of startup interest, there’s starting to be plenty of dreck in … Continue reading “Ed-Tech Isn’t for Wimps: Noodle’s Katzman on Building a Winner”
Lost My iPhone in Royal Danish Moat—Can You Beat That?
I don’t have too many firsts to my name. But I’m betting I’m the first to lose an iPhone 5 in the moat of Rosenborg Castle, the famous Danish royal family castle in the heart of Copenhagen. At least in 2013. It just happened today—luckily my laptop was back at the hotel. I am here … Continue reading “Lost My iPhone in Royal Danish Moat—Can You Beat That?”
Bolt Emerges with $3.5M Fund to Support Hardware Startups in Boston
If hardware is the new black, then Bolt is the new “accelerator.” Actually, Bolt doesn’t much like the term. Instead, it fancies itself a “toolkit” for hardware startups. But the accelerator label gets some mileage, because Bolt has landed in Boston to nurture young companies and build a new business—and, perhaps, a new industry—around connected … Continue reading “Bolt Emerges with $3.5M Fund to Support Hardware Startups in Boston”
The Academy Awards: Biopharma Edition
Academy Award season is upon us, with the Oscars being polished up in anticipation of the big night. Who knows which Hollywood heavyweights and newcomers will be recognized for their seminal contributions to this year’s films? Suppose, however, that there was a drug industry version of the awards. What kind of categories would there be, … Continue reading “The Academy Awards: Biopharma Edition”
Trends to Watch at This Year’s Big AGBT Meeting
Mainstream news stories often mistake technology for science. Such conflation likely reflects how gizmos and knowledge, like arteries and veins, form a virtuous cycle: understanding nature requires, and refines, good tools. In genomics, that symbiosis burns brightest at Advances in Genome Biology & Technology (AGBT), the yearly nucleic acid trip in Florida, where new sequencing … Continue reading “Trends to Watch at This Year’s Big AGBT Meeting”
NeuralIQ Secures $4,352,047 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8f10d0fc-045c-49d7-8deb-23b72e744bd5&Preview=1 Date 2/20/2013 Company Name NeuralIQ Mailing Address 303 Wyman Street Waltham, MA 02451 Company Description CounterTack is the industry’s first and only in-progress attack intelligence and response solution that enables enterprise and government organizations to combat advanced targeted attacks with a new line of defense. Website http://www.countertack.com Transaction Type Venture Equity … Continue reading “NeuralIQ Secures $4,352,047 New Funding Round”
KnowledgeVision Systems Receives $700,726 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=04184347-2a3b-4ab4-a82d-847dab3e79dc&Preview=1 Date 2/20/2013 Company Name KnowledgeVision Systems Mailing Address 55 Old Bedford Road Lincoln, MA 01773 Company Description Finally, an enterprise-level tool for synchronizing video, PowerPoint, footnotes, handout attachments, and images together into engaging, informative experiences available at any time! Website http://www.knowledgevision.com Transaction Type Debt Transaction Amount $700,726 Transaction Round Undisclosed Proceeds … Continue reading “KnowledgeVision Systems Receives $700,726 New Financing”
Crazy Enough to Change the World
Your time is limited, so don’t waste it living someone else’s life. Don’t be trapped by dogma – which is living with the results of other people’s thinking. Don’t let the noise of other’s opinions drown out your own inner voice. And most important, have the courage to follow your heart and intuition. They somehow … Continue reading “Crazy Enough to Change the World”